Investors
Key investment highlights in AlzeCure
- Targeting areas of huge unmet medical needs
- Strong team with extensive experience and track record
- Platforms with first-in-class properties and potential game-changers
- Parallel investments in several candidates and potent follow-up programs
- Multi-billion dollar market opportunity areas
- Phase II company
Financial reports
-
AlzeCure publishes its Year-end report for January – December 2025
February 26, 2026
-
AlzeCure publishes its interim report for January – September 2025
November 11, 2025
-
AlzeCure publishes its interim report for January – June 2025
August 26, 2025
